2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes
- PMID: 11513145
- DOI: 10.1034/j.1600-065x.2001.1810120.x
2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes
Abstract
2B4 is a member of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer (NK) cells and other leukocytes. It is the high affinity ligand for CD48. Engagement of 2B4 on NK-cell surfaces with specific antibodies or CD48 can trigger cell-mediated cytotoxicity, interferon-gamma secretion, phosphoinositol turnover and NK-cell invasiveness. The function of 2B4 in CD8+ T cells and myeloid cells remains unknown. The cytoplasmic domain of 2B4 contains unique tyrosine motifs (TxYxxV/I) that associate with src homology 2 domain-containing protein or signaling lymphocyte activation molecule (SLAM)-associated protein, whose mutation is the underlying genetic defect in the X-linked lymphoproliferative disease (XLPD). Impaired signaling via 2B4 and SLAM is implicated in the immunopathogenesis of XLPD. CS1 is a novel member of the CD2 subset that contains two of the unique tyrosine motifs present in 2B4 and SLAM. Signaling through 2B4, CS1 and other members of the CD2 subset may play a major role in the regulation of NK cells and other leukocyte functions.
Similar articles
-
2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.Hum Immunol. 2000 Jan;61(1):39-43. doi: 10.1016/s0198-8859(99)00170-6. Hum Immunol. 2000. PMID: 10658976 Review.
-
Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.J Immunol. 2005 Jul 15;175(2):1005-13. doi: 10.4049/jimmunol.175.2.1005. J Immunol. 2005. PMID: 16002700
-
Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.Mol Cell Biol. 2004 Jun;24(12):5144-56. doi: 10.1128/MCB.24.12.5144-5156.2004. Mol Cell Biol. 2004. PMID: 15169881 Free PMC article.
-
Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.Blood. 2006 Apr 15;107(8):3181-8. doi: 10.1182/blood-2005-01-0185. Epub 2005 May 19. Blood. 2006. PMID: 15905190 Free PMC article.
-
Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.Immunol Lett. 2006 Jun 15;105(2):180-4. doi: 10.1016/j.imlet.2006.02.006. Epub 2006 Mar 15. Immunol Lett. 2006. PMID: 16621032 Review.
Cited by
-
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma.Blood. 2022 Jun 30;139(26):3708-3721. doi: 10.1182/blood.2021012811. Blood. 2022. PMID: 35090171 Free PMC article.
-
CARs and other T cell therapies for MM: The clinical experience.Best Pract Res Clin Haematol. 2018 Jun;31(2):147-157. doi: 10.1016/j.beha.2018.03.002. Epub 2018 Mar 27. Best Pract Res Clin Haematol. 2018. PMID: 29909915 Free PMC article. Review.
-
NMR structure of the natural killer cell receptor 2B4 (CD244): implications for ligand recognition.Biochemistry. 2005 May 3;44(17):6416-23. doi: 10.1021/bi050139s. Biochemistry. 2005. PMID: 15850375 Free PMC article.
-
CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.Am J Cancer Res. 2017 Aug 1;7(8):1637-1641. eCollection 2017. Am J Cancer Res. 2017. PMID: 28861320 Free PMC article. Review.
-
VISTA is a potential target for immunotherapy in B-cell acute lymphoblastic leukemia in children.Sci Rep. 2025 Jul 3;15(1):23809. doi: 10.1038/s41598-025-08164-2. Sci Rep. 2025. PMID: 40610562 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous